查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1673881

抗毒素市场：按抗毒素类型、依产品类型、依最终用户、按地区

Anti Venom Market, By Anti-venom Type, By Product Type, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2025 年全球抗毒素市场规模为 13.82 亿美元，到 2032 年将达到 24.957 亿美元，2025 年至 2032 年的复合年增长率为 8.8%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 13.82亿美元
效能资料 从2020年到2024年 预测期 2025年至2032年
预测期：2025-2032年复合年增长率： 8.80% 2032年价值预测 24.957亿美元
数字。 2025年抗毒素市场区域份额（%）
抗毒市场-IMG1

全球抗蛇毒血清市场的成长是由于世界热带和亚热带地区蛇咬和蝎子螫伤发生率的上升所致。每年有超过500万人被蛇咬伤，其中约270万人中毒，约10万人死亡。有效驱虫剂的出现提高了许多国家蛇咬伤患者的存活率和康復率，增加了对驱虫剂的需求。领先的製造商正致力于利用最先进的免疫学和生化技术，透过生产技术创新来开发新型抗蛇毒血清。增加投资以提高人们对及时治疗和抗蛇毒血清可用性的认识也可能推动市场成长。

市场动态：

全球抗蛇毒血清市场的成长主要受到全球蛇咬和蝎子螫伤发生率不断增加的推动。根据世界卫生组织统计，每年约有540万人被蛇咬伤，270万人被蜇伤，13.7万人死亡。市场相关人员和政府正在增加投资，以教育农村居民，改善医疗设施的可近性，并确保偏远地区能够获得抗蛇毒血清。但抗蛇毒血清价格昂贵，且保质期短，储存和运输需要限制和管理，限制了其广泛使用。缺乏认识、传统信仰和地理障碍限制了开发中国家的受害者获得及时治疗。研究和生产创新、更有效、更实惠的抗蛇毒血清的市场相关人员可以为市场成长提供机会。

本研究的主要特点

  • 本报告对全球抗毒素市场进行了详细分析，并以 2022 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
  • 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数概述了全球抗毒素市场的主要企业。
  • 本报告的见解可以帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球抗蛇毒血清市场报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球抗蛇毒血清市场的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管情景
  • 收购与合作场景
  • 资金筹措与投资
  • PEST分析
  • 波特的分析

4. 全球抗毒素市场-冠状病毒（COVID-19）大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020 年至 2032 年全球抗毒素市场（按抗毒素类型）

  • 多效价
  • 单一值

6. 2020 年至 2032 年全球抗毒素市场（依产品类型）

  • 抗蛇毒血清
  • 蝎子抗蛇毒血清
  • 蜘蛛抗蛇毒血清
  • 其他的

7. 全球抗毒素市场（依最终用户划分），2020 年至 2032 年

  • 医院和诊所
  • 门诊手术中心
  • 研究所
  • 其他的

8. 2020-2032 年全球抗毒素市场（按地区）

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章竞争格局

  • 公司简介
    • Pfizer, Inc.
    • Merck &Co., Inc.
    • Sanofi Pasteur
    • 4CSL Limited
    • Haffkine Bio-Pharmaceutical Corporation Ltd.
    • Instituto Bioclon SA de CV
    • Rare Disease Therapeutics, Inc.
    • Vins Bioproducts Limited
    • Bharat Serums and Vaccines Limited
    • Serum Institute of India Pvt. Ltd.
    • Incepta Pharmaceuticals Ltd.
    • MicroPharm Limited
    • Laboratorios Silanes SA
    • BTG plc
    • Vacsera
    • Indian Immunologicals Limited
    • AfrIPI（African Institute of Biomedical Science and Technology）

第 10 章分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第 11 章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI1249

Global Anti Venom Market is estimated to be valued at USD 1,382.0 Mn in 2025 and is expected to reach USD 2,495.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1,382.0 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.80% 2032 Value Projection: USD 2,495.7 Mn
Figure. Anti Venom Market Share (%), By Region 2025
Anti Venom Market - IMG1

Global anti venom market growth is driven by rising incidence of snake bites and scorpion stings across tropical and sub-tropical regions of the world. Each year over 5 million people are bitten by snakes, out of which, around 2.7 million cases result in envenoming and around 100,000 deaths. There has been rising demand for anti-venom as the availability of effective anti-venoms has improved survival and recovery rates for victims of snake bites in many countries. Leading manufacturers are engaging in development of novel anti-venoms through reforms in production techniques using modern immunological and biochemical methods. Rising investments towards building awareness about timely treatment and availability of anti-venoms can also drive the market growth.

Market Dynamics:

Global anti venom market growth is primarily driven by increasing incidence of snake bites and scorpion stings globally. According to the World Health Organization, around 5.4 million people suffer from snake bites each year and about 2.7 million are envenomed with around 137,000 deaths. Rising investments by market players and governments towards educating rural populations, improving access to healthcare facilities and ensuring availability of anti-venoms across remote areas can offer lucrative opportunities. However, high costs of anti-venoms, short shelf-life requiring constrained and controlled storage and transportation can limit its widespread adoption. Lack of awareness, traditional beliefs and geographical barriers restrict timely treatment seeking for victims in developing nations. Market players involved in research and production of innovative, more effective and affordable anti-venoms can offer market growth opportunities.

Key features of the study:

  • This report provides in-depth analysis of the global anti venom market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global anti venom market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Bharat Serums & Vaccines, Haffkine Bio-Pharmaceutical Corporation, Vins Bioproducts, Bharat Biotech, and Serum Institute of India
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global anti venom market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti venom market

Detailed Segmentation-

  • By Anti-venom Type
    • Polyvalent
    • Monovalent
  • By Product Type
    • Snake Antivenom
    • Scorpion Anti-venom
    • Spider Anti-venom
    • Others
  • By End User
    • Hospitals & clinics
    • Ambulatory Surgical Centers
    • Research Institutes
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Pfizer, Inc.
    • Merck & Co., Inc.
    • Sanofi Pasteur
    • 4CSL Limited
    • Haffkine Bio-Pharmaceutical Corporation Ltd.
    • Instituto Bioclon S.A. de C.V.
    • Rare Disease Therapeutics, Inc.
    • Vins Bioproducts Limited
    • Bharat Serums and Vaccines Limited
    • Serum Institute of India Pvt. Ltd.
    • Incepta Pharmaceuticals Ltd.
    • MicroPharm Limited
    • Laboratorios Silanes S.A.
    • BTG plc
    • Vacsera
    • Indian Immunologicals Limited
    • AfrIPI (African Institute of Biomedical Science and Technology)

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Anti-venom Type
    • Market Snapshot, By Product Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Anti Venom Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Anti Venom Market, By Anti-venom Type, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Polyvalent
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Monovalent
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Anti Venom Market, By Product Type, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Snake Antivenom
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Scorpion Anti-venom
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Spider Anti-venom
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Anti Venom Market, By End User, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospitals & Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Anti Venom Market, By Region, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Pfizer, Inc.
      • Company Highlights
      • Anti-venom Type Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Anti-venom Type Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sanofi Pasteur
      • Company Highlights
      • Anti-venom Type Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • 4CSL Limited
      • Company Highlights
      • Anti-venom Type Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Haffkine Bio-Pharmaceutical Corporation Ltd.
      • Company Highlights
      • Anti-venom Type Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Instituto Bioclon S.A. de C.V.
      • Company Highlights
      • Anti-venom Type Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Rare Disease Therapeutics, Inc.
      • Company Highlights
      • Anti-venom Type Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Vins Bioproducts Limited
      • Company Highlights
      • Anti-venom Type Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bharat Serums and Vaccines Limited
      • Company Highlights
      • Anti-venom Type Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Serum Institute of India Pvt. Ltd.
    • Incepta Pharmaceuticals Ltd.
    • MicroPharm Limited
    • Laboratorios Silanes S.A.
    • BTG plc
    • Vacsera
    • Indian Immunologicals Limited
    • AfrIPI (African Institute of Biomedical Science and Technology)

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact